4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-17-024343
CIK 0001572552operating
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:30 PM ET
Size
8.6 KB
Accession
0001140361-17-024343
Insider Transaction Report
Form 4
LEBKOWSKI JANE
Pres., Research & Development
Transactions
- Tax Payment
Common Stock
2017-06-05$3.20/sh−7,015$22,448→ 102,991 total
Holdings
- 400,000
Stock Option
Exercise: $2.34From: 2013-08-16Exp: 2020-03-09→ Common Stock (400,000 underlying) - 100,000
Stock Option
Exercise: $3.90From: 2016-02-12Exp: 2025-02-12→ Common Stock (100,000 underlying) - 165,000
Stock Option
Exercise: $3.64From: 2017-02-26Exp: 2026-02-26→ Common Stock (165,000 underlying)
Footnotes (5)
- [F1]In accordance with Rule 16b-3, represents shares withheld by the Issuer to satisfy tax withholding obligation upon vesting of a previously reported restricted stock award.
- [F2]Includes 75,000 Restricted Stock Units to be settled in shares of Common Stock that have not vested as the date hereof.
- [F3]Of such stock options, 16,667 have not vested as of the date hereof.
- [F4]Of such stock options, 43,751 have not vested as of the date hereof.
- [F5]Of such stock options, 113,438 have not vested as of the date hereof.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:30 PM ET
- Size
- 8.6 KB